Skip To Main Content
Jay Patel on Muck Rack

Jay Patel

Manchester
As seen in: Amazon Web Services, CNN, Medium, Ahmedabad Mirror, BBC, Color Research & Application, Forbes, Nature, Washington Post Opinions, Wiley and
Make TV shows and other bits.

Get in touch with Jay

Contact Jay, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

MASH therapy enters a more competitive era Original

|
By Jay Patel
| Clinical Trials Arena Verified
For much of the last two years, there has only been one real way to treat metabolic dysfunction-associated steatohepatitis (MASH). When the US Food and Drug Administration (FDA) approved Madrigal’s resmetirom (Rezdiffra) in March 2024, it was the first marketed drug ever for a disease that affects millions of American adults and is now among the leading causes of liver transplant in the US and Europe.
Open in Who Shared View Duplicates (2) Issue with article?

Rossy AI Shares Practical AI Roadmap for Water Treatment Companies Following CWQA Educational Webinar

|
By Jay Patel
| EIN Presswire
Practical AI Roadmap for Water Treatment Companies Rossy AI outlines practical AI workflows for water treatment companies after CWQA webinar on sales, service, and customer experience. TORONTO, ONTARIO, CANADA, July 2, 2026 / EINPresswire.com/ -- Rossy AI, a Conversational AI Agent platform for service-based businesses, has shared key takeaways from last week’s educational webinar hosted through the Canadian Water Quality Association’s Alternative Tools of the Trade Member Webinar Series.
Open in Who Shared View Duplicates (32) Issue with article?

ASCO 2026: Key Insights In Renal Cell Carcinoma, Merkel Cell Carcinoma, and Chronic Myeloid Leukemia

|
By Rafael Itinoche, Shubh Patel, Jay Patel
| ONCOLOGY journal Verified
In an expert-led review of pivotal clinical trial data presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, CancerNetwork® spoke with oncology experts in the renal cell carcinoma (RCC), Merkel cell carcinoma, and chronic myeloid leukemia (CML) spaces to break down key abstracts at the conference.
Open in Who Shared Issue with article?
See all 338 licensed articles (355 Total)